Scarica l'app Stockscreener
103.30
0.12%
0.125
Precedente Chiudi:
$103.17
Aprire:
$103.4
Volume 24 ore:
199.40K
Relative Volume:
0.33
Capitalizzazione di mercato:
$907.13M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.10%
1M Prestazione:
+2.88%
6M Prestazione:
+16.87%
1 anno Prestazione:
+19.63%
Intervallo 1D:
$102.44
$103.48
Intervallo di 1 settimana:
$102.44
$104.30
Portata 52W:
$77.67
$104.47
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Nome
Vaneck Pharmaceutical Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
103.25 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.89 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.34 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.36 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.80 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Borsa (PPH) Ultime notizie
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase Following Dividend Announcement - Defense World
Osaic Holdings Inc. Has $1.95 Million Stake in VanEck Pharmaceutical ETF $PPH - Defense World
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on December 31, 2025 - marketscreener.com
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Benzinga
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
Why PPH Keeps Working When Single Themes Break (NASDAQ:PPH) - Seeking Alpha
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - sharewise.com
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069 - MSN
Fisher Asset Management LLC Sells 1,263,699 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight - Benzinga
Bank of Montreal Can Sells 4,190 Shares of VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
VanEck Pharmaceutical ETF (Nasdaq:PPH) Stock Quote - FinancialContent
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - TradingView
Avalon Trust Co Lowers Position in VanEck Pharmaceutical ETF $PPH - Defense World
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - TradingView
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110 - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
Top Pharmaceutical Companies Shaping The Future Of Healthcare - Seeking Alpha
Top Pharmaceutical Companies Shaping the Future of Healthcare - VanEck
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet - Benzinga
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Vaneck Pharmaceutical Etf Azioni (PPH) Dati Finanziari
Non sono disponibili dati finanziari per Vaneck Pharmaceutical Etf (PPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):